Graham Capital Wealth Management, LLC Abb Vie Inc. Transaction History

Graham Capital Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $49,167 - $56,623	340 New	340 $54,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.86 Million - $2.3 Million	-14,066 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $1.51 Million - $1.91 Million	14,066 New	14,066 $1.9 Million

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Graham Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Graham Capital Wealth Management, LLC with notifications on news.